| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.663 | 51.830 | 48.976 | 84.037 | 62.543 | 151.808 | 125.249 | 77.981 | 78.402 | 97.675 |
| Total Income - EUR | 2.663 | 51.831 | 48.977 | 84.038 | 62.544 | 151.810 | 125.253 | 78.003 | 78.765 | 97.713 |
| Total Expenses - EUR | 2.283 | 28.765 | 29.291 | 52.913 | 55.684 | 43.751 | 35.914 | 31.967 | 50.182 | 64.752 |
| Gross Profit/Loss - EUR | 380 | 23.066 | 19.686 | 31.124 | 6.860 | 108.058 | 89.339 | 46.036 | 28.583 | 32.961 |
| Net Profit/Loss - EUR | 301 | 22.400 | 19.196 | 30.284 | 6.235 | 106.540 | 88.087 | 45.256 | 27.795 | 31.166 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Sanofit Uno Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 37 | 0 | 5.502 | 13.477 | 9.977 | 6.674 | 5.488 | 3.481 | 10.720 | 9.565 |
| Current Assets | 3.334 | 28.955 | 40.786 | 44.483 | 42.080 | 125.693 | 107.515 | 78.825 | 46.648 | 49.333 |
| Inventories | 1.710 | 1.216 | 516 | 3.129 | 1.476 | 232 | 1.416 | 122 | 8.093 | 4.533 |
| Receivables | 43 | 4.625 | 2.506 | 2.998 | 3.455 | 9.753 | 3.796 | 4.827 | 27.031 | 35.231 |
| Cash | 1.580 | 23.114 | 37.765 | 38.356 | 37.149 | 115.709 | 102.302 | 73.876 | 11.525 | 9.568 |
| Shareholders Funds | 346 | 22.742 | 41.553 | 48.454 | 31.568 | 106.913 | 95.277 | 46.055 | 28.021 | 31.318 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.025 | 6.214 | 4.735 | 9.506 | 20.490 | 25.455 | 17.726 | 36.252 | 36.660 | 28.800 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8129 - 8129" | |||||||||
| CAEN Financial Year |
8129
|
|||||||||
Comments - Sanofit Uno Srl